Backed with $82 million and led by two of BioMarin’s former executives, Mendra plans to acquire rare disease assets and use ...

A Watertown biotech is suspending drug development and laying off essentially all of its workers in a bid to save cash and ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

The Drug Information Association (DIA) today announced the launch of DIA ASCENT, a new global platform designed to support ...

BOSTON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered, clinical-stage biopharma focused on mitochondrial biology and protein homeostasis, today announced it has won the ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

Looking to overcome some of the limitations of existing obesity drugs, Alveus Therapeutics has debuted with nearly $160 million in hand and an impressive roster of executives ready to take the biot | ...

FDA and EMA have issued 10 guiding principles for AI in drug development with the intended goal of ensuring safety and ...

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

The inflation-adjusted cost of developing a new drug now doubles roughly every nine years. To reverse this trend, the ...

Uncover the systematic approach to biotech firm valuation using DCF. Equip yourself with the knowledge to gauge company ...